Friday, June 5, 2026

TOTAL MOBILIZATION: North Korea’s Central Committee Convenes To Announce Major War-Footing Shift

North Korea's year-end plenary meeting reviews national projects and prepares for the upcoming 9th Party Congress.

Are Korean Universities Ready for the Surge in Medical Students?

Seoul's medical schools face faculty shortages and infrastructure issues amid expanded enrollment, raising concerns about education quality.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

Tag: MDD

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us